Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return

Bulletin Express
02/02

Sihuan Pharmaceutical Holdings Group Ltd. (00460) reported that, as of January 31, 2026, the authorized share capital remains at 100,000,000,000 ordinary shares with a par value of HKD 0.01 each, totaling HKD 1,000,000,000. There were no changes from the previous month.

The number of issued shares (excluding treasury shares) remained at 9,145,988,206, and the number of treasury shares stayed at 184,011,000, with no movements during the period. The company confirmed compliance with the applicable public float requirement.

Regarding share options, 60,586,000 options under an exercise price of HKD 0.972 and 7,500,000 options under an exercise price of HKD 2.22 remained outstanding. No new shares were issued or transferred out of treasury shares as a result of the exercise of options during January 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10